Genomic profiling shows BRAF (BRAF-V600E mutant), MEK (MAP2K1), and PI3K (PIK3CA) mutations are common in CRC and associated with aggressive tumors, metastasis, and poor prognosis [11,12,13,14]. Here, MAP2K1 is linked to colorectal carcinoma.